See also this year's filing and all EDGAR filings for this company.
PDF Report 0001938046_2024_Mangoceuticals_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.49876742300050153, 'aggregate_val': 15370511, 'exp_sum': 30665427, 'exp_to_value': {'IntangibleAssets': 15232617, 'AssetsNonCurrent': 15294916, 'AssetsCurrent': 75595, 'PropertyPlantAndEquipment': 2806, 'remainder_Assets': 59493}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001938046, Mangoceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 119,262 |
| 2 | AssetsCurrent | 818,460 |
| 3 | PropertyPlantAndEquipment | 96,129 |
| 4 | remainder_Assets | 16,942 |
| 5 | LongTermLiabilities | 64,961 |
| 6 | LiabilitiesCurrent | 211,078 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 977,890 |
| 9 | CostOfGoodsAndServicesSold | 154,900 |
| 10 | GeneralAndAdministrativeExpense | 3,319,417 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 2,097,505 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 3,400,671 |
| 17 | remainder_Revenues | 731,493 |
| 18 | remainder_NetIncome | 6,473 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,050,793 |
| 1 | Liabilities | 276,039 |
| 2 | Expenses | 9,950,383 |
| 3 | Revenues | 731,493 |
| 4 | StockholdersEquity | 774,754 |
| 5 | NetIncome | -9,212,417 |
| 6 | ComprehensiveNetIncome | -9,212,417 |
| 7 | BaseVar | 6,007,590 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -12.2 |
| 9 | EconomicCapitalRatio | 0.0000000000000320 |
Edgar->Model Mapping
Feature Distribution
